Adaptive Biotechnologies (ADPT) earnings, Nov 4, 2026: EPS −67%, stock +0.4%
In brief
Adaptive Biotechnologies reported on Nov 4, 2026. Earnings per share changed −67% year over year, 122.0% above the estimate; revenue −11%. The stock opened with a +5.2% gap and closed the day +0.4% (Nov 5, 2026). The stock is now 12.7% below its 52-week high, +52.5% over 12 months. Next report: Feb 16, 2027.
EPS vs estimate+122.0%
EPS, YoY−67%
Revenue, YoY−11%
Gap · day+5.2% · +0.4%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 29, 2026 | −1.6% | +7.2% |
| Nov 4, 2026 | +5.2% | +0.4% |
Next-quarter estimates, ratings and the ADPT chart are in the terminal.
Open the terminalFAQ
When is Adaptive Biotechnologies's next earnings report?
Feb 16, 2027. The date comes from daily data and is corrected if the company moves it.
How did Adaptive Biotechnologies stock react to the report?
Opening gap +5.2%, day's result +0.4%.
Did Adaptive Biotechnologies's earnings grow?
Earnings per share fell 67% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.